The book provides a clear and comprehensive description of both personal and clinical recovery in severe mental disorders, including schizophrenia and related disorders, and mood disorders such as major depression and bipolar disorders. Divided into two main parts: r ecovery in schizophrenia and related disorders, and recovery in mood disorders, it offers a broad overview of the factors associated with better or worse outcomes in terms of recovery, as well as the rates (how many people affected by mental disorders may gain recovery), and the time course (how long people affected by mental disorders take to recover) of recovery. It also discusses in detail the pharmacological and psychosocial interventions that can be considered recovery-oriented. Covering the main aspects of recovery in major mental disorders, the book is intended for professionals, scholars, students and anyone interested in mental health.

Discusses both clinical and personal recovery in mental disorders Considers recovery in both non affective and affective disorders Explores the predictors of recovery

Autorentext

Prof. Bernardo Carpiniello is currently a Professor and Chair of Psychiatry, Department of Medical Science and Public Health at the University of Cagliari, Italy, and Director of the Postgraduate School of Psychiatry at the same University, where he has also been the Director of the Psychiatric Clinic since 2000. His main research interests are clinical psychiatry, clinical psychopharmacology, social psychiatry, psychiatric epidemiology and consultation-liaison psychiatry. He has authored or co-authored more than 350 scientific papers, most of which were published in national or international peer-reviewed journals. He is a member of the editorial board of the Journal of Psychopathology, Clinical Practice and Epidemiology in Mental Health, and the Journal of Mental Health Systems, and is co-editor of Case Reports in Medicine. Prof. Carpiniello is currently vice-chair of the Steering Committee of The European Psychiatric Association Council of National Psychiatric Associations. He is a board member of the Italian Society of Psychopathology (SOPSI) and past President of the Italian Society of Psychiatry. He has also been President of the Italian Academic Board of Professors, the Italian Society of Social Psychiatry and the Italian Society of Psychiatric Rehabilitation.

Prof. Antonio Vita is currently a Full Professor of Psychiatry, Dean of the Faculty of Medicine and Surgery of the University of Brescia, Director of the Postgraduate School of Psychiatry at the same University, and Head of the Department of Mental Health, ASST Spedali Civili in Brescia. His research activities focus on clinical, biological, pharmacological and rehabilitative aspects of mental disorders, particularly the neuromorphological and neurofunctional correlates of psychotic disorders, and rehabilitation and cognitive remediation in schizophrenia. Prof. Vita is involved in several international research networks and is the author of over 250 papers published in major national and international scientific journals. He is currently President of the Italian Group for the Study of Cognition in Psychiatry and of the Italian Society of Neuroimaging in Psychiatry, Chair of the World Psychiatric Association's section on neuroimaging, and co-chair of the Section on Schizophrenia of the European Psychiatric Association. He is Vice-President of the Italian Psychiatric Association and is a member of the board of the Italian Association of Biological Psychiatry. He is also on the International Society of Schizophrenia Research's advisory board. He is Co-Editor-in-Chief of the journal Frontiers in Psychiatry - Social Psychiatry and Psychiatric Rehabilitation section, is Deputy Editor of the journal Psychiatry Research and he has been a member of the editorial board of numerous international journals and a regular referee for various leading international psychiatric journals.

Prof. Claudio Mencacci is a Professor at the Postgraduate School of Psychiatry at the State University of Milan, Italy, Director Emeritus Department of Neuroscience and Mental health, Fatebenefratelli Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy, and past Director of the Research Centre on depression and anxiety of the same Hospital, and of the Women's Depression Centre of the Macedonio Melloni Hospital, Milan, Italy. Since 2003 he has been a member of the Italian Ministry of Health's National Observatory on Mental Health, and since 2004 he has been an expert consultant to the Italian Higher Council of Health and vice-President of the IDEA Foundation. From 2012 to 2014 and from 2015 to 2017 he was President of the Italian Psychiatric Association. From 2019 CoPresident Italian Society of NeuropsychoPharmacology Prof. Mencacci has authored more than 250 scientific publications in national and international Journals.

Inhalt
Part 1. Recovery in schizophrenia and related disorders.- 1. Dimensions and Course of Clinical Recovery in Schizophrenia and related disorders.- 2. Determinants of clinical recovery in schizophrenia.- 3. Personal recovery in Schizophrenia: a narrative review.- 4. Personal Recovery within forensic settings.- 5. Stigma And Attitude Towards Personal Recovery From Mental Illness Amongst Italian Mental Health Professionals.- 6. Psychosocial Recovery-Oriented Interventions In Schizophrenia.- 7. Recovery from Psychosis: Emerging definitions, research and select clinical application.- 8. Treatments and recovery to enhance employment outcomes for people with schizophrenia and other major mental disorders: An innovative clinical and organizational model of work inclusion in Milan and surrounding area.- 9. Recovery oriented psychopharmacological interventions in Schizophrenia.- Part 2. Recovery in mood disorders.- 10. Predictors of clinical recovery in bipolar disorders.- 11. Psychosocial recovery-oriented treatments in Bipolar Disorders.- 12. Psychopharmacological recovery-oriented treatments in Bipolar Disorders.- 13. Dimensions and predictors of personal recovery in Major Depression.- 14. Recovery-oriented treatments in major depressive disorder.